Docetaxel/HM-30181A

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDocetaxel/HM-30181A

Drug Alias NameDocetaxel/HM-30181HM-30181A/DocetaxelDocetaxel/HM-30181-A

ClassificationSmall molecules

Mechanisms of ActionTubulin depolymerization inhibitorsP-glycoprotein 1 inhibitors

TargetsTubulinP-glycoprotein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAthenex Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAthenex Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A